From: Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism
 | Male | Female | ANOVA | ||||
---|---|---|---|---|---|---|---|
Parameter | Wistar | GK | Wistar | GK | Phenotype | Sex | Phenotype × sex |
HR (bpm) | 396.22 ± 16.90 | 345.56 ± 27.34* | 388.13 ± 16.36 | 324.67 ± 25.41‡ | <0.001 | 0.343 | 0.67 |
LVPWId (μm/g) | 0.0037 ± 0.0003 | 0.0049 ± 0.0005 | 0.0046 ± 0.0003 | 0.0063 ± 0.0002 | <0.0005 | <0.0005 | 0.31 |
LVPWIs (μm/g) | 0.0060 ± 0.0003 | 0.0073 ± 0.0006†| 0.0083 ± 0.0005 | 0.0102 ± 0.0008 | <0.0005 | <0.0005 | 0.49 |
LVIDId (μm/g) | 0.0150 ± 0.001 | 0.0219 ± 0.001 | 0.0240 ± 0.001 | 0.0291 ± 0.001‡ | <0.0005 | <0.0005 | 0.35 |
LVIDIs (μm/g) | 0.0087 ± 0.0007 | 0.0136 ± 0.0013 | 0.0120 ± 0.0013 | 0.0170 ± 0.0009 | <0.0005 | <0.0005 | 0.82 |
LVMI (mg/g) | 2.45 ± 0.15 | 2.84 ± 0.18* | 2.52 ± 0.10 | 3.04 ± 0.19* | <0.0005 | 0.23 | 0.54 |
FS (%) | 43.45 ± 1.78 | 38.20 ± 4.44 | 48.52 ± 3.91 | 41.57 ± 3.45 | <0.05 | 0.092 | 0.728 |
E (mm/s) | 1041.33 ± 82.04 | 818.50 ± 39.05* | 838.67 ± 49.27 | 750.57 ± 48.21* | <0.01 | <0.01 | 0.161 |
E′ (mm/s) | 54.43 ± 8.10 | 36.26 ± 6.77* | 44.65 ± 3.23 | 30.04 ± 5.51‡ | <0.01 | 0.124 | 0.725 |
A (mm/s) | 813.67 ± 76.65 | 560.50 ± 38.94* | 727.50 ± 57.27 | 535.43 ± 48.99‡ | <0.0005 | 0.257 | 0.528 |
A′ (mm/s) | 51.35 ± 6.4 | 52.27 ± 5.97 | 62.67 ± 5.71 | 55.24 ± 6.07 | 0.527 | 0.173 | 0.419 |